Philip Raskin, MD

Professor
Endowed Title: Clifton and Betsy Robinson Chair in Biomedical Research
Internal Medicine

Contact Information

UT Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75390

philip.raskin@utsouthwestern.edu

To make an appointment, call 214-645-8300.

Education

FellowshipParkland Memorial Hospital, Endocrinology & Metabolism (1971)
ResidencyUniversity of Pittsburgh Medical Center, Internal Medicine (1968)
InternshipUniversity of Pittsburgh Medical Center, Internal Medicine (1967)
Medical SchoolUniversity of Pittsburgh School of Medicine (1966)

Research Interests

Diabetes
Diabetic Complications
Hypertension
Lipid Disorders
New diabetes therapies

Publications

Featured
Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs insulin glargine in the US

J A Ray, W J Valentine, S Roze, L Nicklasson, D Cobden, P Raskin, A Garber, A J Palmer , Diabetes, Obesity, and Metabolism , January 2007; (9(1)):103-113

Featured
Effects of multiple daily insulin injections on peripheral glucose disposal in Latin Americans with type 2 diabetes mellitus

L Aviles-Santa, K Salinas, B Adams-Huet, P Raskin , Journal if Investigative Medicine , January 2007; (55(1)):11-17

Featured
Insulin as initial therapy in type 2 diabetes: effective, safe, and well accepted

I Lingvay, P F Kaloyanova, B Adams-Huet, P Raskin , Journal of Investigative Medicine , 2007; (55(2)):62-68

Featured
Increased erythrocyte aldosed reductase activity in type 1 diabetic patients

Hamada Y, Kito R, and Raskin P , Diabetic Medicine , 1991; (8):226-231

Featured
Independence of cholesterol and fatty acid biosynthesis from cyclic AMP concentration in the perfused rat liver.

Raskin P, McGarry JD, Foster DW , J. Biological Chemistry , 1974; (249):6029

Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes

I Lingvay, P Raskin, L S Szezepaniak , Journal of Diabetes and Its Complications , May 2007; (21(3)):137-142

Basal insulin or premix analogue therapy in type 2 diabetes patients

P Raskin, P A Hollander, A Lewin, R A Gabbay, B Bopde, B Garber, INITIATE Study Group , European Journal of Internal Medicine , January 2007; (18):56-62

Weight gain in type 2 diabetes mellitus

A N Jacob, K Salinas, B Adams-Huet, P Raskin , Diabetes, Obesity and Metabolism , 2007; (9):386-393

Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues

M Brod, D Cobden, M Lammert, D Bushnell, P Raskin , Health and Quality of Life Outcomes , 2007; (5):8

Lung function changes related to diabetes mellitus

C W Hsia, P Raskin , Diabetes Technology & Therapeutics , 2007; (9(1)):S73-S82

Honors/Awards

Alpha Omega Alpha

Owens Fellowship University of Pittsburgh

The Best Doctors In American

1992-1993, 1994-1995, 2001-2002, 2005-2006

Professional Associations/Affiliations

American Diabetes Association

American Society of Clinical Investigation,

Endocrine Society

Fellow American College of Endocrinology,

Fellow American College of Physicians,